https://www.theoncologyshot.com/p/world-first-tumour-agnostic-reimbursementThe Oncology Shot with Timothee Olivieren2026-05-16T11:11:48+00:00World-first tumour-agnostic reimbursement for dual immunotherapy (ipilimumab plus nivolumab), an academic debate, and the DART trial